杏林製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/07/18 | 2,307 | 2,319 | 2,246 | 2,268 | -6 | -0.3% | 146,700 |
2018/07/17 | 2,222 | 2,281 | 2,210 | 2,274 | +102 | +4.7% | 229,000 |
2018/07/13 | 2,158 | 2,178 | 2,155 | 2,172 | +28 | +1.3% | 120,100 |
2018/07/12 | 2,171 | 2,185 | 2,142 | 2,144 | -17 | -0.8% | 136,500 |
2018/07/11 | 2,171 | 2,184 | 2,139 | 2,161 | -35 | -1.6% | 105,100 |
2018/07/10 | 2,230 | 2,246 | 2,196 | 2,196 | -40 | -1.8% | 158,500 |
2018/07/09 | 2,260 | 2,260 | 2,229 | 2,236 | -11 | -0.5% | 85,800 |
2018/07/06 | 2,280 | 2,316 | 2,247 | 2,247 | -8 | -0.4% | 126,600 |
2018/07/05 | 2,244 | 2,273 | 2,244 | 2,255 | +16 | +0.7% | 136,300 |
2018/07/04 | 2,199 | 2,247 | 2,195 | 2,239 | +32 | +1.4% | 104,700 |
2018/07/03 | 2,243 | 2,243 | 2,198 | 2,207 | -36 | -1.6% | 145,600 |
2018/07/02 | 2,290 | 2,297 | 2,243 | 2,243 | -57 | -2.5% | 176,400 |
2018/06/29 | 2,296 | 2,316 | 2,290 | 2,300 | +15 | +0.7% | 247,800 |
2018/06/28 | 2,301 | 2,324 | 2,281 | 2,285 | -30 | -1.3% | 161,500 |
2018/06/27 | 2,301 | 2,324 | 2,300 | 2,315 | -12 | -0.5% | 162,900 |
2018/06/26 | 2,344 | 2,347 | 2,316 | 2,327 | -12 | -0.5% | 124,800 |
2018/06/25 | 2,360 | 2,369 | 2,337 | 2,339 | -17 | -0.7% | 110,400 |
2018/06/22 | 2,349 | 2,369 | 2,329 | 2,356 | -1 | ±0% | 198,300 |
2018/06/21 | 2,380 | 2,387 | 2,340 | 2,357 | +29 | +1.2% | 338,700 |
2018/06/20 | 2,334 | 2,355 | 2,308 | 2,328 | +40 | +1.7% | 211,200 |
2018/06/19 | 2,311 | 2,333 | 2,283 | 2,288 | -22 | -1% | 183,500 |
2018/06/18 | 2,348 | 2,363 | 2,305 | 2,310 | -34 | -1.5% | 135,200 |
2018/06/15 | 2,323 | 2,356 | 2,310 | 2,344 | +32 | +1.4% | 222,700 |
2018/06/14 | 2,305 | 2,322 | 2,286 | 2,312 | +7 | +0.3% | 191,700 |
2018/06/13 | 2,240 | 2,309 | 2,238 | 2,305 | +32 | +1.4% | 186,500 |
2018/06/12 | 2,287 | 2,288 | 2,256 | 2,273 | -14 | -0.6% | 202,700 |
2018/06/11 | 2,300 | 2,302 | 2,284 | 2,287 | +5 | +0.2% | 85,200 |
2018/06/08 | 2,264 | 2,283 | 2,252 | 2,282 | +19 | +0.8% | 265,600 |
2018/06/07 | 2,288 | 2,298 | 2,254 | 2,263 | -16 | -0.7% | 179,900 |
2018/06/06 | 2,270 | 2,283 | 2,237 | 2,279 | -26 | -1.1% | 281,700 |
2018/06/05 | 2,291 | 2,313 | 2,273 | 2,305 | +24 | +1.1% | 206,400 |
2018/06/04 | 2,286 | 2,307 | 2,259 | 2,281 | +10 | +0.4% | 207,500 |
2018/06/01 | 2,259 | 2,298 | 2,236 | 2,271 | +1 | ±0% | 201,900 |
2018/05/31 | 2,280 | 2,290 | 2,259 | 2,270 | -18 | -0.8% | 328,900 |
2018/05/30 | 2,305 | 2,319 | 2,285 | 2,288 | -59 | -2.5% | 199,100 |
2018/05/29 | 2,346 | 2,360 | 2,330 | 2,347 | -14 | -0.6% | 181,900 |
2018/05/28 | 2,392 | 2,406 | 2,349 | 2,361 | -45 | -1.9% | 166,100 |
2018/05/25 | 2,407 | 2,418 | 2,390 | 2,406 | -7 | -0.3% | 221,900 |
2018/05/24 | 2,428 | 2,429 | 2,404 | 2,413 | -4 | -0.2% | 202,200 |
2018/05/23 | 2,445 | 2,466 | 2,387 | 2,417 | -28 | -1.1% | 269,300 |
2018/05/22 | 2,449 | 2,469 | 2,431 | 2,445 | +6 | +0.2% | 207,500 |
2018/05/21 | 2,450 | 2,464 | 2,425 | 2,439 | -6 | -0.2% | 209,300 |
2018/05/18 | 2,448 | 2,468 | 2,426 | 2,445 | +19 | +0.8% | 285,400 |
2018/05/17 | 2,416 | 2,448 | 2,413 | 2,426 | +21 | +0.9% | 352,700 |
2018/05/16 | 2,335 | 2,414 | 2,335 | 2,405 | +83 | +3.6% | 573,400 |
2018/05/15 | 2,260 | 2,334 | 2,260 | 2,322 | +72 | +3.2% | 340,800 |
2018/05/14 | 2,210 | 2,256 | 2,209 | 2,250 | +41 | +1.9% | 231,500 |
2018/05/11 | 2,155 | 2,216 | 2,155 | 2,209 | +38 | +1.8% | 360,300 |
2018/05/10 | 2,146 | 2,200 | 2,103 | 2,171 | +24 | +1.1% | 310,900 |
2018/05/09 | 2,152 | 2,186 | 2,130 | 2,147 | -9 | -0.4% | 309,200 |
1551~
1600
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
JCRファーマ | 72,400円 | -3.7% | -36.7% | 2.76% | 23.84倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
栄研化 | 209,200円 | +0.4% | -8.4% | 2.53% | 27.65倍 | 1.57倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム